Operating Income for DaVita (DVA)
According to DaVita's latest reported financial statements, the company's current operating income (TTM) is $2.03B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DVA
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$2.03B
YoY change
-3.8%
5Y CAGR
+3.5%
Peak year (2024)
$2.09B
Cumulative operating income
$31.50B
Operating Income history chart for DaVita (DVA) from 1994 to 2025
Operating Income history table for DaVita (DVA) from 1994 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $2.01B | -3.8% | ||
| 2024 | $2.09B | +30.4% | ||
| 2023 | $1.60B | +19.7% | ||
| 2022 | $1.34B | -25.5% | ||
| 2021 | $1.80B | +6.1% | ||
| 2020 | $1.69B | +3.1% | ||
| 2019 | $1.64B | +7.7% | ||
| 2018 | $1.53B | -15.8% | ||
| 2017 | $1.81B | -10.7% | ||
| 2016 | $2.03B | +78.6% | ||
| 2015 | $1.14B | -37.4% | ||
| 2014 | $1.82B | +17.1% | ||
| 2013 | $1.55B | +19.5% | ||
| 2012 | $1.30B | +12.3% | ||
| 2011 | $1.15B | +16.2% | ||
| 2010 | $993.81M | +5.7% | ||
| 2009 | $940.27M | +8.2% | ||
| 2008 | $869.10M | +0.8% | ||
| 2007 | $862.21M | +16.6% | ||
| 2006 | $739.43M | +58.9% | ||
| 2005 | $465.37M | +22.1% | ||
| 2004 | $381.13M | +5.9% | ||
| 2003 | $359.93M | -6.2% | ||
| 2002 | $383.83M | +23.5% | ||
| 2001 | $310.86M | +73.4% | ||
| 2000 | $179.27M | +136.4% | ||
| 1999 | $75.82M | -64.4% | ||
| 1998 | $213.00M | +90.9% | ||
| 1997 | $111.60M | +52.3% | ||
| 1996 | $73.30M | +174.5% | ||
| 1995 | $26.70M | +55.2% | ||
| 1994 | $17.20M | — |
Operating Income values are taken from DaVita's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of DaVita (DVA) operating income is $2.01B – edged down 3.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, DaVita operating income compounded at +3.5% per year, with the latest reading among the more recent periods of the dataset.
Between 2024 and 2025, DaVita operating income edged down 3.8%, falling from $2.09B to $2.01B.
$2.09B stands as the all-time-high annual operating income, posted in 2024, against a low of $17.20M during 1994.
Within Healthcare, DaVita (DVA) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
DaVita Operating Income by Year
DaVita Operating Income 2025: $2.01B
DaVita operating income in 2025 was $2.01B, edged down 3.8% below 2024.
DaVita Operating Income 2024: $2.09B
DaVita operating income in 2024 was $2.09B, surged 30.4% from 2023. This figure represents the highest annual value in the available history.
DaVita Operating Income 2023: $1.60B
DaVita operating income in 2023 was $1.60B, grew 19.7% from 2022.
DaVita Operating Income 2022: $1.34B
DaVita operating income in 2022 was $1.34B, declined 25.5% below 2021.
DaVita Operating Income 2021: $1.80B
DaVita operating income in 2021 was $1.80B.
See more financial history for DaVita (DVA).
Sector peers — Operating Income
Companies in the same sector as DaVita, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is DaVita's operating income?
- Latest reported operating income for DaVita (DVA) is $2.03B (period ending December 31, 2025).
How has DaVita operating income changed year-over-year?
- DaVita (DVA) operating income changed -3.8% year-over-year on the latest annual filing.
What is the long-term growth rate of DaVita operating income?
- DaVita (DVA) operating income compound annual growth rate is +3.5% over the most recent 5 years available.
When did DaVita operating income hit its highest annual value?
- DaVita operating income reached its highest annual value of $2.09B in 2024.
What was DaVita operating income in 2024?
- DaVita (DVA) operating income in 2024 was $2.09B.
What was DaVita operating income in 2025?
- DaVita (DVA) operating income in 2025 was $2.01B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DVA Overview
Company profile, financial tools, and key metrics
DVA Revenue Counter
Earns $432.62 every second. See per minute, hour, and day.
DVA Earnings Counter
Earns $23.68 per second net profit. See per minute, hour, and day.
DVA Economic Scale
Exceeds Namibia's GDP. Compare with world economies.
DVA What If Invested
What if you had invested $1,000? See historical returns from any date.
DVA How It Makes Money
Discover visual breakdown of $13.64B in revenue — where it comes from and where it goes.
DVA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DVA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DVA Daily Price Character
Balanced · 50.5% historical win rate (green days). Streaks & record days.
DVA Buybacks
18.33% TTM buyback yield. Shareholder yield & SBC comparison.
DVA Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.